Retinal Function

Ophthalmology
0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Oxurion
OxurionBelgium - Leuven
1 program
Retinal and Cognitive Dysfunction in Type 2 DiabetesN/A
Genesis Therapeutics
Genesis TherapeuticsCA - Burlingame
1 program
Retinal and Cognitive Dysfunction in Type 2 DiabetesN/A1 trial
Active Trials
NCT04281186CompletedEst. Dec 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Genesis TherapeuticsRetinal and Cognitive Dysfunction in Type 2 Diabetes

Clinical Trials (1)

NCT04281186Genesis TherapeuticsRetinal and Cognitive Dysfunction in Type 2 Diabetes

Retinal and Cognitive Dysfunction in Type 2 Diabetes

Start: Nov 2020Est. completion: Dec 2024
N/ACompleted

Related Jobs in Ophthalmology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space